Safety and Efficacy Study of Pitavastatin in Patient With a Metabolic Syndrome

Inclusion Criteria: * Patients aged between 18 and 75 * Patients with LDL ≥ 100mg/dL * Patients with metabolic syndrome 1. IFG: Fasting glucose ≥ 100mg/dL 2. Abdominal Obesity: Waist circumference: men≥90cm,women≥85cm 3. 1 or more of the following 1. Triglyceride ≥ 150mg/dL 2. HDL-C: men \< 40mg/dL, women \< 50mg/dL 3. Blood pressure: SBP ≥ 130mmHg or DBP ≥ 85mmHg or subject receiving anti-hypertensive treatment Exclusion Criteria: * uncontrolled hypertension (DBP ≥ 95mmHg) * taking diabetic drugs or with HbA1c \> 8% * LDL ≥ 190mg/dL or Triglyceride ≥ 400mg/dL * coronary heart disease or other diseases caused by artherosclerosis * malignancy within 6 months * Serum creatinine ≥ 2.0mg/dL * ALT or AST ≥ ULN\*2.5 * CPK ≥ ULN\*2 * hypothyroidism